Divi's Laboratories reported a robust financial performance for the third quarter of FY25, with net profit rising 64.5% year-over-year to ₹589 crore, exceeding market expectations of ₹507 crore. Revenue from operations increased by 25% to ₹2,319 crore, driven by strong growth in Custom Synthesis, which rose 44%. The company's EBITDA surged 52% to ₹743 crore, resulting in an improved margin of 32%. In contrast, KPR Mill's net profit increased by 8.2% to ₹202.3 crore, with revenue up 23.2% to ₹1,529 crore. Meanwhile, Tube Investments reported a slight revenue increase of 0.3% to ₹1,910 crore, and net profit rose 2.2% to ₹161 crore. Gland Pharma experienced a 6.7% rise in net profit to ₹204.7 crore, although revenue fell by 10.4% to ₹1,384 crore. Asian Paints reported a 23.5% decline in net profit to ₹1,128 crore, with revenues decreasing by 6% to ₹8,549 crore. Tata Power's net profit rose 10.4% to ₹1,187.5 crore, while revenue increased by 5% to ₹15,391 crore.